These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34272731)

  • 1. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
    Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
    Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
    Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
    Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 4. pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Teoh SH; Khoo JJ; Abdul Salam DSD; Peh SC; Cheah SC
    Malays J Pathol; 2019 Dec; 41(3):273-281. PubMed ID: 31901912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma.
    Morichika K; Karube K; Sakihama S; Watanabe R; Kawaki M; Nishi Y; Nakachi S; Okamoto S; Takahara T; Satou A; Shimada S; Shimada K; Tsuzuki T; Fukushima T; Morishima S; Masuzaki H
    Am J Surg Pathol; 2021 Jun; 45(6):832-840. PubMed ID: 33899787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV
    Liu H; Xu-Monette ZY; Tang G; Wang W; Kim Y; Yuan J; Li Y; Chen W; Li Y; Fedoriw GY; Zhu F; Fang X; Luedke C; Medeiros LJ; Young KH; Hu S
    Histopathology; 2022 Feb; 80(3):575-588. PubMed ID: 34637146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
    Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
    J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
    Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
    Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.
    Gebauer N; Künstner A; Ketzer J; Witte HM; Rausch T; Benes V; Zimmermann J; Gebauer J; Merz H; Bernard V; Harder L; Ratjen K; Gesk S; Peter W; Busch Y; Trojok P; von Bubnoff N; Biersack H; Busch H; Feller AC
    Blood Cancer J; 2021 May; 11(5):102. PubMed ID: 34039950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
    J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
    Cassim S; Antel K; Chetty DR; Oosthuizen J; Opie J; Mohamed Z; Verburgh E
    Pathology; 2020 Jun; 52(4):453-459. PubMed ID: 32305135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of EBV associated diffuse large B-cell lymphoma.
    Frontzek F; Staiger AM; Wullenkord R; Grau M; Zapukhlyak M; Kurz KS; Horn H; Erdmann T; Fend F; Richter J; Klapper W; Lenz P; Hailfinger S; Tasidou A; Trautmann M; Hartmann W; Rosenwald A; Quintanilla-Martinez L; Ott G; Anagnostopoulos I; Lenz G
    Leukemia; 2023 Mar; 37(3):670-679. PubMed ID: 36604606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of B-cell post-transplant lymphoproliferative disorders.
    Menter T; Juskevicius D; Alikian M; Steiger J; Dirnhofer S; Tzankov A; Naresh KN
    Br J Haematol; 2017 Jul; 178(1):48-56. PubMed ID: 28419429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
    Morton LM; Kim CJ; Weiss LM; Bhatia K; Cockburn M; Hawes D; Wang SS; Chang C; Altekruse SF; Engels EA; Cozen W
    Leuk Lymphoma; 2014 Mar; 55(3):551-7. PubMed ID: 23772639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
    Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
    Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.
    Hoffmann JC; Chisholm KM; Cherry A; Chen J; Arber DA; Natkunam Y; Warnke RA; Ohgami RS
    Hum Pathol; 2016 Feb; 48():9-17. PubMed ID: 26772393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
    Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
    Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.